105 related articles for article (PubMed ID: 15168357)
1. Neuropeptides, apoptosis and ion changes in prostate cancer. Methods of study and recent developments.
Vilches J; Salido M; Fernández-Segura E; Roomans GM
Histol Histopathol; 2004 Jul; 19(3):951-61. PubMed ID: 15168357
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines.
Salido M; Vilches J; López A; Roomans GM
Cancer; 2002 Jan; 94(2):368-77. PubMed ID: 11900223
[TBL] [Abstract][Full Text] [Related]
3. Changes in elemental concentrations in LNCaP cells are associated with a protective effect of neuropeptides on etoposide-induced apoptosis.
Salido M; Vilches J; Roomans GM
Cell Biol Int; 2004; 28(5):397-402. PubMed ID: 15193283
[TBL] [Abstract][Full Text] [Related]
4. Intracellular Elemental Patterns of Apoptosis Resistance in Transdifferentiated Androgen-Dependent Prostatic Carcinoma Cells.
Salido M; Vilches J
Microsc Microanal; 2016 Aug; 22(4):865-77. PubMed ID: 27487730
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine pathogenesis in adenocarcinoma of the prostate.
Hansson J; Abrahamsson PA
Ann Oncol; 2001; 12 Suppl 2():S145-52. PubMed ID: 11762343
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines.
Salido M; Vilches J; López A
Histol Histopathol; 2000 Jul; 15(3):729-38. PubMed ID: 10963117
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
Alberti C
G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
[TBL] [Abstract][Full Text] [Related]
8. X-ray microanalysis of etoposide-induced apoptosis in the PC-3 prostatic cancer cell line.
Salido M; Vilches J; Lopez A; Roomans GM
Cell Biol Int; 2001; 25(6):499-508. PubMed ID: 11407855
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine cells in prostate cancer.
Amorino GP; Parsons SJ
Crit Rev Eukaryot Gene Expr; 2004; 14(4):287-300. PubMed ID: 15663358
[TBL] [Abstract][Full Text] [Related]
11. The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells.
Alonzeau J; Alexandre D; Jeandel L; Courel M; Hautot C; El Yamani FZ; Gobet F; Leprince J; Magoul R; Amarti A; Pfister C; Yon L; Anouar Y; Chartrel N
Eur J Cancer; 2013 Jan; 49(2):511-9. PubMed ID: 22863147
[TBL] [Abstract][Full Text] [Related]
12. New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
Sciarra A; Cardi A; Dattilo C; Mariotti G; Di Monaco F; Di Silverio F
Int J Clin Pract; 2006 Apr; 60(4):462-70. PubMed ID: 16620361
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells.
Humez S; Monet M; Legrand G; Lepage G; Delcourt P; Prevarskaya N
Endocr Relat Cancer; 2006 Mar; 13(1):181-95. PubMed ID: 16601287
[TBL] [Abstract][Full Text] [Related]
15. Loss of mitochondrial membrane potential is inhibited by bombesin in etoposide-induced apoptosis in PC-3 prostate carcinoma cells.
Salido M; Gonzalez JL; Vilches J
Mol Cancer Ther; 2007 Apr; 6(4):1292-9. PubMed ID: 17431107
[TBL] [Abstract][Full Text] [Related]
16. Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation.
Albrecht M; Doroszewicz J; Gillen S; Gomes I; Wilhelm B; Stief T; Aumüller G
Prostate; 2004 Jan; 58(1):82-94. PubMed ID: 14673956
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the neuropeptides bombesin and calcitonin on the growth of prostate cell lines, PC-3, DU 145, and LNCaP].
Larrán López J; Aparicio Patino J; López Muñoz A; Vilches Troya J
Actas Urol Esp; 2000; 24(10):779-84. PubMed ID: 11199293
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN
Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
[TBL] [Abstract][Full Text] [Related]
19. [The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells].
Song Y; Wu G; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(23):1453-6. PubMed ID: 15733464
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
Valentini A; Biancolella M; Amati F; Gravina P; Miano R; Chillemi G; Farcomeni A; Bueno S; Vespasiani G; Desideri A; Federici G; Novelli G; Bernardini S
Drug Metab Dispos; 2007 Jun; 35(6):968-72. PubMed ID: 17371798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]